<?xml version="1.0" encoding="UTF-8"?>
<p>Much like managing an epidemic is more challenging when a city has 10â€…000 cases rather than 10, managing a SARS CoV-2 lung infection is more difficult when the entire tissue is overrun with virus, rather than a small portion. There is a longstanding precedent that early treatment of viruses leads to better outcomes. In a trial of Ebola treatment, shorter symptom duration at presentation correlated with lower viral load, and it increased the likelihood that interventions would be lifesaving [
 <xref rid="CIT0012" ref-type="bibr">12</xref>]. Early influenza treatment causes shorter duration of shedding and symptoms [
 <xref rid="CIT0013" ref-type="bibr">13</xref>]. For human immunodeficiency virus (HIV), early treatment confers mortality benefits and lowers community transmission [
 <xref rid="CIT0014" ref-type="bibr">14</xref>, 
 <xref rid="CIT0015" ref-type="bibr">15</xref>].
</p>
